MDT250110C76000
- 2.75
- 0.000.00%
Medtronic Newsroom
TechInsights: It is predicted that smart watch sales will grow by 5% in 2025.
After experiencing a decline in smartwatch sales for six consecutive quarters, the market began to mature, the proportion of new buyers started to decrease, and smartwatch sales returned to a growth trajectory.
Musk: The goal this year is to produce thousands of Siasun Robot&Automation humanoid robots, with production increasing tenfold each year over the next two years.
Musk stated that if everything goes smoothly, the production of humanoid robots will increase tenfold by 2026, with the goal of producing between 0.05 million to 0.1 million humanoid robots next year, and then increasing it tenfold again the following year.
Bernstein Maintains Medtronic(MDT.US) With Buy Rating, Cuts Target Price to $93
Johnson & Johnson Falls After Pausing Varipulse Cases
State-of-the-Art Intraoperative 3D Imaging Now Offered at Nicklaus Children's Hospital
Medtronic Spinal Division Inks Agreement With Kuros Biosciences
Piper Sandler Maintains Medtronic(MDT.US) With Hold Rating
Hysteroscopy Instruments Market Research 2024-2028 & 2033 Featuring Major Players - Medtronic, Fujifilm, Stryker, Boston Scientific, and B. Braun Melsungen
Implantable Neurostimulation Devices Market Research 2024-2028 & 2033, Competitive Analysis of Major Players - Abbott Laboratories, Medtronic, Boston Scientific, Dignity Health, & St. Jude Medical
Is Medtronic's Dividend Safe?
Bernstein Maintains Medtronic(MDT.US) With Buy Rating, Raises Target Price to $97
NVIDIA open-sources the world's foundational models, humanoid robots accelerate towards the 'ChatGPT moment'.
① Recently, NVIDIA launched the physical AI model Cosmos, which is capable of predicting environments such as warehouses and road conditions to train Siasun Robot&Automation; ② According to NVIDIA's disclosed list, the first batch of users for Cosmos includes manufacturers such as 1X, Agility, Figure AI, and Xiaopeng Autos; ③ Brokerages believe that in the collection methods of training data for humanoid robots, synthetic data will greatly promote the development of robots.
RBC Capital Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $105
RBC Capital Sticks to Its Buy Rating for Medtronic (MDT)
Diabetes Device Maker Beta Bionics Files for $100M IPO
Anteris Technologies Positioned To Capture 4%-5% Of US Transcatheter Valve Replacement Market By 2030: Analyst
Fire1 Raises $120M for Breakthrough Heart Failure Management Tech With Investment From Medtronic
Endologix Announces Leadership Transition
Kuros Biosciences USA, Inc. Announces an Exclusive Strategic Agreement With the Medtronic Spinal Division
Medtronic Chairman and CEO Geoff Martha to Speak at J.P. Morgan Healthcare Conference